Jude Onyia

CIK: 0001894425

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (20.5%)

Position reduction

Option Exercises (M)13 (33.3%)

Derivative conversions

Awards (A)6 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)12 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NBIX

NEUROCRINE BIOSCIENCES INC

Officer

VYGR

Voyager Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (39 total)

NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Award(A)
Direct
3.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $156.22$302K
NBIX
NEUROCRINE BIOSCIENCES INC
Aug 4, 2026
Gift(G)
Direct
2.4K shares-
VYGR
Voyager Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 5, 2026
Gift(G)
Direct
2.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 1, 2026
Sale(S)
Direct
11K shares at avg. $160.25$1.8M
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 1, 2026
Exercise(M)
Direct
11K shares at avg. $84.74$932K
NBIX
NEUROCRINE BIOSCIENCES INC
May 27, 2026
Exercise(M)
Direct
11K shares at avg. $84.74$932K
NBIX
NEUROCRINE BIOSCIENCES INC
May 27, 2026
Sale(S)
Direct
11K shares at avg. $155.53$1.7M
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 20, 2026
Gift(G)
Direct
3.1K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
10.8K shares at avg. $124.12$1.3M
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $124.12$182K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Direct
19.9K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
2.7K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
1.5K shares at avg. $124.12$180K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
2.7K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $123.10$176K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Exercise(M)
Direct
2.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Exercise(M)
Direct
238 shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Tax Payment(F)
Direct
142 shares at avg. $136.06$19K
NBIX
NEUROCRINE BIOSCIENCES INC
Nov 29, 2025
Tax Payment(F)
Direct
2.2K shares at avg. $152.16$342K
NBIX
NEUROCRINE BIOSCIENCES INC
Nov 29, 2025
Exercise(M)
Direct
4.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 3, 2025
Gift(G)
Direct
1.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Aug 5, 2025
Gift(G)
Direct
3.1K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jul 9, 2025
Sale(S)
Direct
59.8K shares at avg. $130.46$7.8M

		Type	Shares	Price		Ownership
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	3,587	-	$0	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,936	$156.22	$302,442	Direct
Aug 4, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	2,409	-	$0	Direct
Jun 9, 2026	VYGR Voyager Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Jun 5, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	2,441	-	$0	Direct
Jun 1, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	11,000	$160.25	$1,762,710	Direct
Jun 1, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	11,000	$84.74	$932,140	Direct
May 27, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	11,000	$84.74	$932,140	Direct
May 27, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	11,000	$155.53	$1,710,865	Direct
Feb 20, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	3,110	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	10,755	$124.12	$1,334,911	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,466	$124.12	$181,960	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	19,935	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,690	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,452	$124.12	$180,222	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,717	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,426	$123.10	$175,541	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,560	-	$0	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	238	-	$0	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	142	$136.06	$19,321	Direct
Nov 29, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	2,248	$152.16	$342,056	Direct
Nov 29, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	4,426	-	-	Direct
Sep 3, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	1,470	-	-	Direct
Aug 5, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	3,116	-	-	Direct
Jul 9, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	59,819	$130.46	$7,803,688	Direct

1-25 of 39 transactions

About Onyia Jude

Onyia Jude (SEC CIK 0001894425) files insider reports with the SEC as Chief Scientific Officer of NEUROCRINE BIOSCIENCES INC (NBIX) and Director of Voyager Therapeutics, Inc. (VYGR).

Signal8 holds 18 ownership filings by Onyia Jude, all Form 4s, filed between Dec 3, 2024 and Sep 15, 2026. Those filings report 39 transactions, from Nov 29, 2024 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Onyia Jude's filings is in SAN DIEGO, CA.

Recent filings by Onyia Jude

Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
Aug 4, 2026: Gift of NBIX shares (Form 4, code G).
Jun 9, 2026: Grant or award of VYGR derivative securities (Form 4, code A).
Jun 5, 2026: Gift of NBIX shares (Form 4, code G).

Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)

MORROW GEORGE J, Director
Gano Kyle, Chief Executive Officer
ROBERTS EIRY, Chief Medical Officer
Lippoldt Darin, Chief Legal Officer
Keswani Sanjay Chandru, Chief Medical Officer
GORMAN KEVIN CHARLES, Director

How to read Form 4 transaction codes